8mg retatrutide Shop Retatrutide Dosing Guide for Researchers

Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity

Retatrutide differs from semaglutide and tirzepatide because it targets three pathways (GLP-1, GIP, and glucagon)

If you and your clinician decide to stop, the practical approach is: Step down through the available dose levels at 4-week intervals (12 mg 9 mg 6 mg 4 mg 2 mg off) rather than stopping abruptly

Those with PCOS may be more likely to experience this type of cycle change, which is also in line with previous research where GLP-1 medications have shown some promise for improving menstrual cycle regularity in women with PCOS

Retatrutide targets GLP-1, GIP, and glucagon receptors simultaneously, producing substantial weight loss in phase 2 studies